SPY311.36-0.82 -0.26%
DIA263.33+0.16 0.06%
IXIC9,615.81-67.10 -0.69%
News
CBMG
--
0.00%
--
Edited Transcript of CBMG earnings conference call or presentation 6-May-20 9:00pm GMT
Thomson Reuters StreetEvents · 2d ago
Hedge Funds Are Warming Up To Cellular Biomedicine Group, Inc. (CBMG)
Insider Monkey · 05/27 22:20
Cellular Biomedicine Group (CBMG) Announces 2020 Annual Meeting of Stockholders
PR Newswire · 05/26 13:00
Cellular Biomedicine Group, Inc. (CBMG) CEO Tony Liu on Q1 2020 Results - Earnings Call Transcript
Seeking Alpha - Transcript · 05/09 17:18
Cellular Biomedicine Group Inc (CBMG) Q1 2020 Earnings Call Transcript
Motley Fool · 05/07 20:31
Cellular Biomedicine EPS beats by $0.16
Cellular Biomedicine (NASDAQ:CBMG): Q1 GAAP EPS of -$0.60 beats by $0.16. Cash, equivalents and restricted cash of $21.6M (+40.3% Q/Q) Press Release
seekingalpha · 05/07 02:01
Cellular Biomedicine Group Reports Q1 2020 Financial Results and Business Highlights
PR Newswire · 05/06 21:16
Cellular Biomedicine Gr Q1 EPS $(0.600) Down From $(0.510) YoY
Cellular Biomedicine Gr (NASDAQ:CBMG) reported quarterly losses of $(0.600) per share. This is a 17.65 percent decrease over losses of $(0.510) per share from the same period last year.
Benzinga · 05/06 20:50
The Daily Biotech Pulse: FDA Nod For AstraZeneca, AbbVie-Allergan Deal Clears Antitrust Hurdle
Here's a roundup of top developments in the biotech space over the last 24 hours. Scaling The Peak (Biotech Stocks Hitting 52-week Highs May 5)
Benzinga · 05/06 14:36
Cellular Biomedicine Group to Report First Quarter 2020 Results on May 6, 2020
PR Newswire · 05/01 21:15
Cellular Biomedicine on go with China study of CAR T for multiple myeloma
seekingalpha · 04/04 01:36
Benzinga's Top Upgrades, Downgrades For March 5, 2020
Upgrades
Benzinga · 03/05 15:05
BTIG Research Downgrades Cellular Biomedicine Gr to Neutral
BTIG Research analyst Amanda Murphy downgrades Cellular Biomedicine Gr (NASDAQ:CBMG) from Buy to Neutral.
Benzinga · 03/05 09:48
Cellular Biomedicine Group's (CBMG) CEO Tony Liu on Q4 2019 Results - Earnings Call Transcript
Seeking Alpha - Transcript · 03/02 16:23
Cellular Biomedicine Group Announces Q4 and Full Year 2019 Financial Results and Recent Operational Progress
PR Newswire · 02/28 21:05
Cellular Biomedicine Group Inc (CBMG) Q4 2019 Earnings Call Transcript
MotleyFool.com · 02/28 05:00
Cellular Biomedicine Group to Report Fourth Quarter and Full Year 2019 Results on February 28, 2020
PR Newswire · 02/26 14:00
Cellular Biomedicine Says Received New Prelim. Non-Binding Proposal For $19.50/Share
On February 21, 2020, the Special Committee of the Board of Directors (the “Special Committee”) of Cellular Biomedicine Group, Inc. (the “Company”) received a new preliminary non-binding proposal
Benzinga · 02/24 13:26
Cellular Biomedicine Group Announces Engagement Of Independent Advisors By Special Committee Formed To Evaluate Strategic Alternatives Including $19.50/Share Preliminary Non-Binding Proposal
Cellular Biomedicine Group, Inc. (NASDAQ:CBMG) ("CBMG") today announced that the special committee of its board of directors, composed of Alan Au, Edward Schafer, Terry A. Belmont and Wen Tao (Steve) Liu,
Benzinga · 12/30/2019 13:31
Cellular Biomedicine Group Announces Engagement of Independent Advisors by Special Committee
PR Newswire · 12/30/2019 13:30